Retrospective evaluation of fidaxomicin versus oral vancomycin for treatment of Clostridium difficile infections in allogeneic stem cell transplant

Objective/background: Clostridium difficile infection (CDI) is a potential complication during hematopoietic stem cell transplantation (HSCT), and no specific recommendations exist regarding treatment of CDI in allogeneic SCT patients. Use of metronidazole and oral vancomycin has been associated wit...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Laura Prohaska, Zahra Mahmoudjafari, Leyla Shune, Anurag Singh, Tara Lin, Sunil Abhyankar, Siddhartha Ganguly, Dennis Grauer, Joseph McGuirk, Lisa Clough
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Wolters Kluwer Medknow Publications 2018-10-01
Цуврал:	Hematology/Oncology and Stem Cell Therapy
Нөхцлүүд:	allogeneic stem cell transplantation clostridium difficile fidaxomicin vancomycin
Онлайн хандалт:	https://journals.lww.com/10.1016/j.hemonc.2018.05.001
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!